Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Safety of MabThera (Rituximab) Maintenance Therapy in Patients With Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy.

NCT00430352 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00430352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00430352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Safety of MabThera (Rituximab) Maintenance Therapy in Patients With Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy.
Lead sponsor
Hoffmann-La Roche
Phase
Phase 4
Overall status
Completed
Start date
September 4, 2006
Completion date
May 26, 2011
Enrollment
545 (actual)
Sites
178

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin's lymphoma